Moreover, the overexpression of bFGF in pancreatic cancer tissue was associated with poor prognosis, as indicated by Ghaneh et al. [124], thus evidencing the role of this growth factor in significant correlations with survival and/or treatment responsiveness in pancreatic cancer patients. Here, FGF2 is linked to familial pancreatic carcinoma.